Inter- and intra-tumor heterogeneity of genetic and immune profiles in inherited renal cell carcinoma

Cell Rep. 2023 Jul 25;42(7):112736. doi: 10.1016/j.celrep.2023.112736. Epub 2023 Jul 4.

Abstract

Patients with von Hippel-Lindau disease (vHL) are at risk of developing spatially and temporally multiple clear cell renal cell carcinomas (ccRCCs), which offers a valuable opportunity to analyze inter- and intra-tumor heterogeneity of genetic and immune profiles within the same patient. Here, we perform whole-exome and RNA sequencing, digital gene expression, and immunohistochemical analyses for 81 samples from 51 ccRCCs of 10 patients with vHL. Inherited ccRCCs are clonally independent and have less genomic alterations than sporadic ccRCCs. Hierarchical clustering of transcriptome profiles shows two clusters with distinct immune signatures: immune hot and cold clusters. Interestingly, not only samples from the same tumors but also different tumors from the same patients tend to show a similar immune signature, whereas samples from different patients frequently exhibit different signatures. Our findings reveal the genetic and immune landscape of inherited ccRCCs, demonstrating the relevance of host factors in shaping anti-tumor immunity.

Keywords: CP: Cancer; clear cell renal cell carcinoma; copy-number alteration; hereditary cancer syndrome; heterogeneity; immune profile; mutation; tumor microenvironment; von Hippel-Lindau disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Carcinoma* / genetics
  • Carcinoma, Renal Cell* / genetics
  • Carcinoma, Renal Cell* / pathology
  • Humans
  • Kidney Neoplasms* / genetics
  • Kidney Neoplasms* / pathology
  • Mutation
  • Von Hippel-Lindau Tumor Suppressor Protein / genetics
  • Von Hippel-Lindau Tumor Suppressor Protein / metabolism
  • von Hippel-Lindau Disease* / genetics
  • von Hippel-Lindau Disease* / pathology

Substances

  • Von Hippel-Lindau Tumor Suppressor Protein